Page last updated: 2024-10-25

ciglitazone and Goldblatt Syndrome

ciglitazone has been researched along with Goldblatt Syndrome in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tyagi, N1
Moshal, KS1
Lominadze, D1
Ovechkin, AV1
Tyagi, SC1

Other Studies

1 other study available for ciglitazone and Goldblatt Syndrome

ArticleYear
Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:7

    Topics: Acetylcholine; Animals; Blotting, Western; Collagen; Endothelin-1; Endothelium, Vascular; Fibrosis;

2005